December 7, 2017 / 6:38 AM / in 4 days

BRIEF-Mithra Announces Valorization Of French Subsidiary

Dec 7 (Reuters) - Mithra Pharmaceuticals Sa:

* MITHRA ANNOUNCES VALORIZATION OF FRENCH SUBSIDIARY

* SUCCESSFULLY DIVESTED ITS FRENCH AFFILIATE, MITHRA FRANCE‍​

* SALE CONSISTS OF TWO AGREEMENTS

* FIRST CONTRACT IS CLOSED WITH LABORATOIRE CCD

* ON CONTRACT LABORATOIRE CCD: CONCERNS TRANSFER OF MARKETING AUTHORIZATIONS FOR 4 PRODUCTS

* LABORATOIRE CCD CONTRACT: HAS 10-YEAR EXCLUSIVE TIBELIA LICENSE&SUPPLY AGREEMENT IN FRANCE

* LABORATOIRE CCD CONTRACT: MITHRA ELIGIBLE FOR UPFRONT PAYMENT AND FUTURE ROYALTIES FOR 4 PRODUCTS OVER 5 YRS

* COMMERCIAL LAUNCH OF TIBELIA IN FRANCE IS EXPECTED IN H2 2018

* OTHER CONTRACT: SHARE PURCHASE AGREEMENT FOR MITHRA FRANCE WITH THERAMEX

* THERAMEX WILL TAKE OVER SUBSIDIARY INCLUDING ITS PHARMACEUTICAL LICENSE

* FINANCIAL DETAILS OF AGREEMENTS WERE NOT DISCLOSED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below